Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

News Details

(14/07/2026 17:02)

Ajanta Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

As of June 2026, 63.49% is owned by Indian Promoters and 36.52% by Public.

Institutional holds 29.48% (Insurance Companies 3.29%) and Non-Institutional holds 7.03% as Public shareholders.

Top five Promoters holding highest number of shares of Ajanta Pharma company are Rajesh M Agrawal, trustee Rajesh Agrawal Trust (180.78 lakhs shares / 14.47%), Yogesh M Agrawal, trustee Yogesh Agrawal Trust (180.78 lakhs shares / 14.47%), Aayush M Agrawal, trustee Aayush Agrawal Trust (141.13 lakhs shares / 11.30%), Ravi P Agrawal, trustee Ravi Agrawal Trust (127.93 lakhs shares / 10.24%) and Gabs Investments Pvt Ltd (125.88 lakhs shares / 10.08%).

Out of 793.14 lakhs shares, Promoters of Ajanta Pharma Company has over 178.71 lakhs (22.53%) shares on pledge as of June 30, 2026.
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
CDSL – MyEasi App App Store: https://apps.apple.com/in/app/cdsl-myeasi-app/id6737304195      Google Play Store: https://play.google.com/store/apps/details?id=com.cdsl.myeasi   |   NSDL – Speede App : App Store: https://apps.apple.com/in/app/nsdl-speede-app/id922834763      Google Play Store: https://play.google.com/store/apps/details?id=com.msf.NSDL.Android